$Cassava Sciences (SAVA.US)$ Biogen’s controversial AD drug ...
$Cassava Sciences(SAVA.US$ Biogen’s controversial AD drug with brain bleed and killing people announced it’s done today but yet stock price is up 6%. SAVA has no safety issues and in phase 3 trials improving cognition on mild patients. Yeah, we know what shorts are doing. The best drug to actually treat people safely is SAVA
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
